Loading...
NYSE: TMO
Thermo Fisher Scientific Inc.
Healthcare · Medical - Diagnostics & Research
●S&P 500 since 2004
Market Cap
$172.32B
52w High
$643.99
52w Low
$385.46
P/E
25.97
Volume
958.90K
Outstanding Shares
371.48M
Company profile
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.
CEOMarc N. Casper
SectorHealthcare
IndustryMedical - Diagnostics & Research
Employees125,000
IPO dateMar 17, 1980
Valuation
Forward P/E—
EV/EBITDA21.71
Enterprise value$248.87B
Stock splits
Jun 6, 19963:2
May 25, 19953:2
Oct 29, 19933:2
Nov 3, 19863:2
Sep 17, 19853:2
Jan 4, 19843:2
Jul 10, 19793:2
Nov 19, 19732:1
Profitability & growth
Revenue growth7.2%
Gross margin39.46%▼8.92%vs FY2024
Operating margin17.96%▲1.85%vs FY2024
ROE12.61%▼1.27%vs FY2024
Analyst consensus
RatingBuy
Target price$650.58▲40.25%
38
Buy
4
Hold
0
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
Apr 22, 2026
View
EPS
Actual vs estimate by quarter
Q2FY25
ActualEst.
$5.36
$5.23
Q3FY25
ActualEst.
$5.79
$5.50
Q4FY25
ActualEst.
$6.57
$6.45
Q1FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q2FY25
ActualEst.
$10.86B
$10.68B
Q3FY25
ActualEst.
$11.12B
$10.92B
Q4FY25
ActualEst.
$12.22B
$11.95B
Q1FY26
Next Est.
—